91³ÉÈ˰涶Òô

Dr Simon Ghaly

Conjoint Senior Lecturer
Medicine & Health
School of Clinical Medicine
  • Book Chapters | 2023
    Wark G; Samocha-Bonet D; Ghaly S; Danta M, 2023, 'The role of nutrition in inflammatory bowel disease: Disease associations, management of active disease and maintenance of remission', in Encyclopedia of Human Nutrition: Volume 1-4, Fourth Edition, pp. 669 - 697,
  • Journal articles | 2024
    Alshiwanna B; McNamara J; Wilson WE; Pipicella JL; Ghaly S; Gearry R; Begun J; Williams A-J; Lynch KD; Lawrance IC; Schultz M; Walker GJ; Radford-Smith GL; Connor SJ; Andrews JM, 2024, 'Mo1835 DOSE ESCALATED INFLIXIMAB IN INFLAMMATORY BOWEL DISEASE - CROHN'S COLITIS CURE (CCC) DATA INSIGHTS PROGRAM', Gastroenterology, 166, pp. S - 1135,
    Journal articles | 2024
    Alshiwanna B; Mcnamara J; Wilson W; Pipicella JL; Ghaly S; Gearry R; Begun J; Williams A; Lynch K; Lawrance I; Schultz M; Walker G; Radford-Smith G; Connor SJ; Andrews JM, 2024, 'P1005 Dose escalated Infliximab in Inflammatory Bowel Disease - Crohn's Colitis Cure (CCC) Data Insights Program', Journal of Crohn's and Colitis, 18, pp. i1818 - i1818,
    Journal articles | 2024
    Barnett M; Mcnamara J; Wilson W; Pipicella J; Ghaly S; Gearry R; Begun J; Williams A; Lynch K; Lawrance I; Schultz M; Walker G; Radford-Smith G; Connor SJ; Andrews JM, 2024, 'P1012 Dose escalated Ustekinumab in Inflammatory Bowel Disease - Crohn's Colitis Cure (CCC) Data Insights Program', Journal of Crohn's and Colitis, 18, pp. i1829 - i1829,
    Journal articles | 2024
    Barnett MI; McNamara J; Wilson WE; Pipicella JL; Ghaly S; Gearry R; Begun J; Williams A-J; Lynch KD; Lawrance IC; Schultz M; Walker GJ; Radford-Smith GL; Connor SJ; Andrews JM, 2024, 'Mo1833 DOSE ESCALATED USTEKINUMAB IN INFLAMMATORY BOWEL DISEASE - CROHN'S COLITIS CURE (CCC) DATA INSIGHTS PROGRAM', Gastroenterology, 166,
    Journal articles | 2024
    Katsoudas N; Tavakoli P; Wu N; Shapiro A; Leach ST; Williams AJ; Paramsothy R; Ghaly S; Connor SJ; Samocha-Bonet D; Lambert K; Hold GL, 2024, 'Dietary Emulsifier Exposure in People with Inflammatory Bowel Disease Compared with Healthy Controls: Is There a Cause for Concern?', Inflammatory Bowel Diseases, 30, pp. 1241 - 1250,
    Journal articles | 2024
    Lim E; Thai M; An Y-K; Hendy P; Alchlaihawi M; Leong R; Connor S; Ng W; Gu B; Thin L; Sparrow M; Gilmore R; Taylor K; Sallis O; Andrews JM; Daker C; Gearry RB; Wark G; Ghaly S; Begun M; Krishnaprasad K; Wu T; Ruddick-Collins L; Schreiber V; Okano S; Radford-Smith G; Schulberg J; van Langenberg D; Begun J, 2024, 'High Technical Success Rate of Endoscopic Balloon Dilatation Reduces Surgical Requirement for Patients With Stricturing Crohn’s Disease', GastroHep, 2024,
    Journal articles | 2024
    McNamara J; Alshiwanna B; Wilson WE; Pipicella JL; Ghaly S; Gearry R; Begun J; Ng W; Lynch KD; Lawrance IC; Schultz M; Walker GJ; Radford-Smith GL; Andrews JM; Connor SJ, 2024, 'Mo1834 DOSE ESCALATED VEDOLIZUMAB IN INFLAMMATORY BOWEL DISEASE - CROHN'S COLITIS CURE (CCC) DATA INSIGHTS PROGRAM', Gastroenterology, 166, pp. S - 1135,
    Journal articles | 2024
    McNamara J; Wilson W; Pipicella JL; Ghaly S; Begun J; Lawrance IC; Gearry R; Andrews JM; Connor SJ, 2024, 'Epidemiology and Treatment Patterns of Fistulising Crohn’s Disease in a large, real-world Australasian cohort', Gastro Hep Advances, pp. 100594 - 100594,
    Journal articles | 2024
    McNamara J; Wilson WE; Pipicella JL; Ghaly S; Gearry R; Begun J; Ng W; Lynch KD; Lawrance IC; Schultz M; Walker GJ; Radford-Smith GL; Andrews JM; Connor SJ, 2024, 'Su1841 VARIATION IN OUTCOMES IN INFLAMMATORY BOWEL DISEASE AT TEN AUSTRALASIAN CENTRES - CROHN'S COLITIS CURE (CCC) DATA INSIGHTS PROGRAM', Gastroenterology, 166, pp. S - 839,
    Journal articles | 2024
    McNamara J; Wilson WE; Pipicella JL; Ghaly S; Gearry R; Williams A-J; Lynch KD; Lawrance IC; Schultz M; Walker GJ; Radford-Smith GL; Connor SJ; Andrews JM, 2024, 'Su1874 THE BURDEN OF MENTAL HEALTH DISEASE IN PEOPLE WITH INFLAMMATORY BOWEL DISEASE - CROHN'S COLITIS CURE (CCC) DATA INSIGHTS PROGRAM', Gastroenterology, 166,
    Journal articles | 2024
    Mcnamara J; Alshiwanna B; Wilson W; Pipicella JL; Ghaly S; Gearry R; Begun J; Ng W; Lynch K; Lawrance I; Schultz M; Walker G; Radford-Smith G; Andrews JA; Connor SJ, 2024, 'P959 Dose escalated vedolizumab in Inflammatory Bowel Disease - Crohn's Colitis Cure (CCC) Data Insights Program', Journal of Crohn's and Colitis, 18, pp. i1742 - i1742,
    Journal articles | 2024
    Mcnamara J; Wilson W; Pipicella J; Ghaly S; Gearry R; Begun J; Ng W; Lynch K; Lawrance I; Schultz M; Walker G; Radford-Smith G; Andrews JM; Connor SJ, 2024, 'P286 Variation of outcomes in inflammatory bowel disease at ten Australasian centres - Crohn's Colitis Cure (CCC) Data Insights Program', Journal of Crohn's and Colitis, 18, pp. i657 - i657,
    Journal articles | 2024
    Mcnamara J; Wilson W; Pipicella JL; Ghaly S; Gearry R; Begun J; Ng W; Lynch K; Lawrance I; Schultz M; Walker G; Radford-Smith G; Andrews JM; Connor SJ, 2024, 'P1129 Fistulising Crohn's Disease in a large Australasian cohort - Crohn's Colitis Cure (CCC) Data Insights Program', Journal of Crohn's and Colitis, 18, pp. i2023 - i2023,
    Journal articles | 2024
    Mcnamara J; Wilson W; Pipicella JL; Ghaly S; Gearry R; Williams A; Lynch K; Lawrance I; Schultz M; Walker G; Radford-Smith G; Connor SJ; Andrews JM, 2024, 'P462 The burden of mental health disease in people with inflammatory bowel disease - Crohn's Colitis Cure (CCC) Data Insights Program', Journal of Crohn's and Colitis, 18, pp. i930 - i930,
    Journal articles | 2024
    Pipicella JL; McNamara J; Wilson W; Lynch K; Walker G; Begun J; Lawrance I; Ghaly S; Radford-Smith G; Williams AJ; Gearry R; Schultz M; Brett L; Andrews JM; Connor SJ, 2024, 'P880 The real-world use of five-aminosalicylate (5ASA) treatment for Ulcerative Colitis in Australia and New Zealand: Crohn’s Colitis Cure (CCC) data insight’s program', Journal of Crohn's and Colitis, 18, pp. i1622 - i1623,
    Journal articles | 2024
    Pipicella JL; McNamara J; Wilson WE; Lynch KD; Walker GJ; Begun J; Lawrance IC; Ghaly S; Radford-Smith GL; Williams A-J; Gearry R; Schultz M; Brett L; Andrews JM; Connor SJ, 2024, 'Tu1891 THE REAL-WORLD USE OF FIVE-AMINOSALICYLATE (5ASA) TREATMENT FOR ULCERATIVE COLITIS IN AUSTRALIA AND NEW ZEALAND: CROHN'S COLITIS CURE (CCC) DATA INSIGHT'S PROGRAM', Gastroenterology, 166,
    Journal articles | 2024
    Pipicella JL; Wilson W; Ghaly S; Antoniades S; Kate L; Grafton R; Ng W; Sechi A; Somes K; Arnold K; Connor SJ; Andrews JM, 2024, 'P1030 Inflammatory Bowel Disease helpline contact trends in a real-world Australasian cohort: Crohn’s Colitis Cure (CCC) data insight’s program', Journal of Crohn's and Colitis, 18, pp. i1858 - i1859,
    Journal articles | 2024
    Pudipeddi A; Paramsothy S; Kariyawasam V; Paramsothy R; Ghaly S; Haifer C; An YK; Begun J; Connor SJ; Corte C; Ward MG; De Cruz P; Lan-San Fung C; Redmond D; Chan W; Mourad F; Kermeen M; Leong RW, 2024, 'Effects of Thiopurine Withdrawal on Vedolizumab-Treated Patients With Ulcerative Colitis: A Randomized Controlled Trial', Clinical Gastroenterology and Hepatology, 22, pp. 2299 - 2308.e5,
    Journal articles | 2024
    Wark G; Kaakoush NO; Samocha-Bonet D; Ghaly S; Danta M, 2024, 'Dietary Determinants of Metabolic and Gut Microbial Health in Patients with Inflammatory Bowel Disease', Nutrients, 16,
    Journal articles | 2024
    Wark G; Kaakoush NO; Samocha-Bonet D; Ghaly S; Danta M, 2024, 'P1233 Serum insulin is associated with c-reactive protein and gut microbial diversity in inflammatory bowel disease', Journal of Crohn's and Colitis, 18, pp. i2183 - i2183,
    Journal articles | 2023
    An YK; Lindsay N; Allan N; Khoo E; Fernandes R; Amiss A; Pham H; Wong KF; Ooi SY; Thin L; Lightowler D; Connor SJ; Williams AJ; De Cruz P; Li Wai Suen C; Kariyawasam V; Mitrev N; Ghaly S; Andrews JM; Christensen B; Sparrow MP; White LS; Bryant RV; Ding N; Leong R; Van Langenberg D; Seltenreich H; Subramaniam K; Radford-Smith G; Begun J, 2023, 'P663 Post-ustekinumab induction IL12, IL23, and ustekinumab levels are associated with clinical response in a multi-centre prospective cohort study of Crohn’s disease patients: results from the AURORA Study including ANZIBDC Cohort', Journal of Crohn's and Colitis, 17, pp. i793 - i794,
    Journal articles | 2023
    Cheema M; Narouz I; Pipicella J; Garden F; Lynch K; Andrews J; Ghaly S; Connor S, 2023, 'P523 Quality, safety and equity of care outcomes for inflammatory bowel disease patients at four tertiary referral centres in Australia using a cloud based management system Crohn’s Colitis Care (CCCare): A real world observational study.', Journal of Crohn's and Colitis, 17, pp. i650 - i651,
    Journal articles | 2023
    Cheema M; Pipicella JL; Narouz I; Garden F; Cabaero A; Williams A-J; Ng W; Wark G; Antoniades S; Kim A; Haifer C; McGrory L; Lynch KD; Andrews JM; Ghaly DS; Connor SJ, 2023, 'Su1782 QUALITY, SAFETY AND EQUITY OF CARE OUTCOMES FOR INFLAMMATORY BOWEL DISEASE PATIENTS AT FOUR AUSTRALIAN TERTIARY REFERRAL CENTRES USING THE CLOUD-BASED MANAGEMENT SYSTEM CROHN'S COLITIS CARE (CCCARE) : A REAL WORLD OBSERVATIONAL STUDY', Gastroenterology, 164, pp. S - 679,
    Journal articles | 2023
    Pudipeddi A; Paramsothy S; Kariyawasam V; Paramsothy R; Ghaly S; Haifer C; An YK; Begun J; Connor S; Corte C; Ward M; De Cruz P; Fung C; Redmond D; Leong RW, 2023, 'P413 Withdrawal versus continuation of thiopurine in vedolizumab-treated patients with Ulcerative Colitis (VIEWS): a multi-centre randomised controlled trial', Journal of Crohn's and Colitis, 17, pp. i542 - i543,
    Journal articles | 2023
    Pudipeddi A; Paramsothy S; Kariyawasam VC; Paramsothy R; Ghaly DS; Haifer C; An Y-K; Begun J; Connor SJ; Corte C; Ward M; De Cruz P; Fung C; Chan PW; Mourad FH; Redmond D; Leong R, 2023, '1029 WITHDRAWAL VERSUS CONTINUATION OF THIOPURINE IN VEDOLIZUMAB-TREATED PATIENTS WITH ULCERATIVE COLITIS (VIEWS): A MULTI-CENTRE RANDOMISED CONTROLLED TRIAL', Gastroenterology, 164, pp. S - 221,
    Journal articles | 2023
    Suo P; Thin L; Srinivasan A; Winston J; Jeffrey A; Menon S; Ghaly S; Haifer C, 2023, 'P753 Comparing long-term outcomes in inflammatory bowel disease patients between switch and non-switch cohorts: no differences in infliximab persistence or safety outcomes after 54 months', Journal of Crohn's and Colitis, 17, pp. i884 - i885,
    Journal articles | 2022
    Ghali M; Bensted K; Williams DB; Ghaly S, 2022, 'Type 2 autoimmune pancreatitis associated with severe ulcerative colitis: Three case reports', World Journal of Clinical Cases, 10, pp. 8788 - 8796,
    Journal articles | 2022
    Gu B; Williams AJ; Ng W; Xuan W; Connor S; Gholamrezaei A; Corte C; Venkatesh K; Ghaly S; Paramsothy S, 2022, 'Higher infliximab and adalimumab trough levels are associated with fistula healing in patients with fistulising perianal Crohn's disease', World Journal of Gastroenterology, 28, pp. 2597 - 2608,
    Journal articles | 2022
    Haifer C; Paramsothy S; Kaakoush NO; Saikal A; Ghaly S; Yang T; Luu LDW; Borody TJ; Leong RW, 2022, 'Lyophilised oral faecal microbiota transplantation for ulcerative colitis (LOTUS): a randomised, double-blind, placebo-controlled trial', The Lancet Gastroenterology and Hepatology, 7, pp. 141 - 151,
    Journal articles | 2021
    Haifer C; Saikal A; Paramsothy S; Borody TJ; Ghaly DS; Kaakoush NO; Leong RW, 2021, '680 LYOPHILIZED ORALLY ADMINISTERED FECAL MICROBIOTA TRANSPLANTATION IN THE MANAGEMENT OF ULCERATIVE COLITIS (LOTUS STUDY) – RESULTS FROM THE INDUCTION PHASE OF A RANDOMIZED CONTROLLED TRIAL', Gastroenterology, 160, pp. S - 135,
    Journal articles | 2021
    Haifer C; Saikal A; Paramsothy S; Borody TJ; Ghaly S; Kaakoush NO; Leong R, 2021, 'Lyophilised orally administered faecal microbiota transplantation for Active Ulcerative Colitis (LOTUS study)', JOURNAL OF CROHNS & COLITIS, 15, pp. S029 - S029,
    Journal articles | 2021
    Haifer C; Srinivasan A; An YK; Picardo S; van Langenberg D; Menon S; Begun J; Ghaly S; Thin L, 2021, 'Switching Australian patients with moderate to severe inflammatory bowel disease from originator to biosimilar infliximab: a multicentre, parallel cohort study', Medical Journal of Australia, 214, pp. 128 - 133,
    Journal articles | 2021
    Prentice RE; Rentsch C; Al-Ani AH; Zhang E; Johnson D; Halliday J; Bryant R; Begun J; Ward MG; Lewindon PJ; Connor SJ; Ghaly S; Christensen B, 2021, 'SARS-CoV-2 vaccination in patients with inflammatory bowel disease.', GastroHep, 3, pp. 212 - 228,
    Journal articles | 2021
    Wark G; Samocha-Bonet D; Ghaly S; Danta M, 2021, 'The role of diet in the pathogenesis and management of inflammatory bowel disease: A review', Nutrients, 13, pp. 1 - 26,
    Journal articles | 2021
    Williams AJ; Paramsothy R; Wu N; Ghaly S; Leach S; Paramsothy S; Corte C; O'Brien C; Burke C; Wark G; Samocha-Bonet D; Lambert K; Ahlenstiel G; Wasinger V; Dutt S; Pavli P; Grimm M; Lemberg D; Connor S; Leong R; Hold G, 2021, 'Australia IBD Microbiome (AIM) Study: Protocol for a multicentre longitudinal prospective cohort study', BMJ Open, 11,
    Journal articles | 2020
    Aysha AA; Rentsch C; Prentice R; Johnson D; Bryant RV; Ward MG; Costello SP; Lewindon P; Ghaly S; Connor SJ; Begun J; Christensen B, 2020, 'Practical management of inflammatory bowel disease patients during the COVID-19 pandemic: expert commentary from the Gastroenterological Society of Australia Inflammatory Bowel Disease faculty', Internal Medicine Journal, 50, pp. 798 - 804,
    Journal articles | 2020
    Ghaly S; Kaakoush NO; Hart PH, 2020, 'Effects of UVR exposure on the gut microbiota of mice and humans', Photochemical and Photobiological Sciences, 19, pp. 20 - 28,
    Journal articles | 2020
    Haifer C; Kelly CR; Paramsothy S; Andresen D; Papanicolas LE; McKew GL; Borody TJ; Kamm M; Costello SP; Andrews JM; Begun J; Chan HT; Connor S; Ghaly S; Johnson PDR; Lemberg DA; Paramsothy R; Redmond A; Sheorey H; Van Der Poorten D; Leong RW, 2020, 'Australian consensus statements for the regulation, production and use of faecal microbiota transplantation in clinical practice', Gut, 69, pp. 801 - 810,
    Journal articles | 2020
    McGrath-Cadell L; Bart NK; Lin L; Ghaly S; Holloway CJ, 2020, 'Myocarditis in Crohn's disease: A case report', European Heart Journal - Case Reports, 4, pp. 1 - 6,
    Journal articles | 2020
    Reddy Pulusu SS; Srinivasan A; Krishnaprasad K; Cheng D; Begun J; Keung C; Van Langenberg D; Thin L; Mogilevski T; de Cruz P; Radford-Smith G; Flanagan E; Bell S; Kashkooli S; Sparrow M; Ghaly S; Bampton P; Sawyer E; Connor S; Rizvi QUA; Andrews JM; Mahy G; Chivers P; Travis S; CraigLawrance I, 2020, 'Vedolizumab for ulcerative colitis: Real world outcomes from a multicenter observational cohort of Australia and Oxford', World Journal of Gastroenterology, 26, pp. 4428 - 4441,
    Journal articles | 2020
    Wu Y; Ghaly S; Kerr S; Jackson B; Hanigan K; Martins D; Krishnaprasad K; Mountifield RE; Whiteman DC; Bampton PA; Gearry RB; Radford-Smith GL; Lawrance IC, 2020, 'Level of UV Exposure, Skin Type, and Age Are More Important than Thiopurine Use for Keratinocyte Carcinoma Development in IBD Patients', Digestive Diseases and Sciences, 65, pp. 1172 - 1179,
    Journal articles | 2019
    Ghaly S; Hart PH; Lawrance IC, 2019, 'Inflammatory bowel diseases: interrelationships between dietary vitamin D, exposure to UV radiation and the fecal microbiome', Expert Review of Gastroenterology and Hepatology, 13, pp. 1039 - 1048,
    Journal articles | 2019
    Haifer C; Lawrance IC; Center JR; Clarke MW; Hart PH; Eisman JA; Lucas R; Ghaly S, 2019, 'Vitamin D metabolites are lower with active Crohn’s disease and spontaneously recover with development of remission', Therapeutic Advances in Gastroenterology, 12,
    Journal articles | 2019
    Iliff J; Bart NK; Ghaly S; Granger E; Holloway CJ, 2019, 'Pericardial Mesothelioma in a 35-Year-Old Male With Ulcerative Colitis', Circulation. Cardiovascular imaging, 12, pp. e008659,
    Journal articles | 2018
    Flanagan E; Gibson PR; Begun J; Ghaly S; Garg M; Andrews JM; Rosella O; Rosella G; Bell SJ, 2018, 'Letter: vedolizumab drug concentrations in neonates following intrauterine exposure', Alimentary Pharmacology and Therapeutics, 48, pp. 1328 - 1330,
    Journal articles | 2018
    Ghaly S; Bliuc D; Center JR; Clarke MW; Jones AP; Trend S; Kermode AG; Neale RE; Hart PH, 2018, 'Vitamin D C3-epimer levels are proportionally higher with oral vitamin D supplementation compared to ultraviolet irradiation of skin in mice but not humans.', The Journal of Steroid Biochemistry and Molecular Biology, 186, pp. 110 - 116,
    Journal articles | 2018
    Ghaly S; Kaakoush NO; Lloyd F; Gordon L; Forest C; Lawrance IC; Hart PH, 2018, 'Ultraviolet irradiation of skin alters the faecal microbiome independently of vitamin D in mice', Nutrients, 10,
    Journal articles | 2018
    Ghaly S; Kaakoush NO; Lloyd F; McGonigle T; Mok D; Baird A; Klopcic B; Gordon L; Gorman S; Forest C; Bouillon R; Lawrance IC; Hart PH, 2018, 'High Dose Vitamin D supplementation alters faecal microbiome and predisposes mice to more severe colitis', Scientific Reports, 8,
    Journal articles | 2018
    Ghaly S, 2018, 'What is in our treasure chest? Australian pharmaceutical benefits scheme availability and criteria for prescribing biologics', Journal of Gastroenterology and Hepatology (Australia), 33, pp. 12 - 13,
    Journal articles | 2018
    Haifer C; Lucas RM; Clarke MW; Lawrance I; Hart PH; Center JR; Eisman JA; Ghaly S, 2018, 'P120 Vitamin D deficiency in Crohn’s disease', Journal of Crohn's and Colitis, 12, pp. S152 - S153,
    Journal articles | 2018
    Pulusu SSR; Srinivasan A; Krishnaprasad K; Cheng D; Mogilevski T; Flanagan E; Keung C; Wu C; Prosser R; Sawyer E; Rizvi Q-U-A; Su H; Leung W-K; Edmundson A; Cooke S; Mahy G; Thin L; Radford-Smith G; Sparrow M; Andrews JM; Connor S; Bampton P; Ghaly S; Van Langenberg D; Bell S; De Cruz P; Begun J; Ng S; Travis S; Lawrance I, 2018, 'P571 Vedolizumab (VDZ) real-world outcomes in ulcerative colitis (UC)', Journal of Crohn's and Colitis, 12, pp. S395 - S396,
    Journal articles | 2017
    McGonigle TA; Keane KN; Ghaly S; Carter KW; Anderson D; Scott NM; Goodridge HS; Dwyer A; Greenland E; Pixley FJ; Newsholme P; Hart PH, 2017, 'UV Irradiation of Skin Enhances Glycolytic Flux and Reduces Migration Capabilities in Bone Marrow-Differentiated Dendritic Cells.', Am J Pathol, 187, pp. 2046 - 2059,
    Journal articles | 2017
    Mitrev N; Vande Casteele N; Seow CH; Andrews JM; Connor SJ; Moore GT; Barclay M; Begun J; Bryant R; Chan W; Corte C; Ghaly S; Lemberg DA; Kariyawasam V; Lewindon P; Martin J; Mountifield R; Radford-Smith G; Slobodian P; Sparrow M; Toong C; van Langenberg D; Ward MG; Leong RW, 2017, 'Review article: consensus statements on therapeutic drug monitoring of anti-tumour necrosis factor therapy in inflammatory bowel diseases', Alimentary Pharmacology and Therapeutics, 46, pp. 1037 - 1053,
    Journal articles | 2017
    Wu Y; Ghaly S; Kerr S; Krishnaprasad K; Martins D; Jackson B; Prosser R; Hanigan K; Mountifield RE; Whiteman D; Bampton PA; Gearry R; Radford-Smith GL; Lawrance I, 2017, 'UV Exposure and Skin Type are More Important than Thiopurine Exposure for Non-Melanoma Skin Cancer Risk in IBD', Gastroenterology, 152, pp. S576 - S576,
    Journal articles | 2017
    Wu Y; Ghaly S; Kerr S; Krishnaprasad K; Prosser R; Jackson B; Hanigan K; Martins D; Mountifield R; Whiteman D; Bampton P; Gearry R; Radford-Smith G; Lawrance IC, 2017, 'P691 UV exposure and skin type are more important than thiopurine exposure for non-melanoma skin cancer risk in IBD', Journal of Crohn's and Colitis, 11, pp. S433 - S434,
    Journal articles | 2016
    Andrews JM; Costello SP; Agarwal AK; Bampton P; Beswick L; Connor S; Ghaly S; O'Connor S; Pudipeddi A; Sechi A; Sparrow M; Walsh AJ, 2016, 'Conflict of interest: Real and perceived - a more mature consideration is needed', Internal Medicine Journal, 46, pp. 377 - 379,
    Journal articles | 2016
    Ghaly S; Murray K; Baird A; Martin K; Prosser R; Mill J; Simms LA; Hart PH; Radford-Smith G; Bampton PA; Lawrance IC, 2016, 'High Vitamin D-Binding Protein Concentration, Low Albumin, and Mode of Remission Predict Relapse in Crohn's Disease.', Inflamm Bowel Dis, 22, pp. 2456 - 2464,
    Journal articles | 2015
    Costello SP; Ghaly S; Beswick L; Pudipeddi A; Agarwal A; Sechi A; O'Connor S; Connor SJ; Sparrow MP; Bampton P; Walsh AJ; Andrews JM, 2015, 'Compassionate access anti-tumour necrosis factor-α therapy for ulcerative colitis in Australia: The benefits to patients', Internal Medicine Journal, 45, pp. 659 - 666,
    Journal articles | 2015
    Ghaly S; Costello S; Beswick L; Pudipeddi A; Agarwal A; Sechi A; Antoniades S; Headon B; Connor S; Lawrance IC; Sparrow M; Walsh AJ; Andrews JM, 2015, 'Dose tailoring of anti-tumour necrosis factor-alpha therapy delivers useful clinical efficacy in Crohn disease patients experiencing loss of response', Internal Medicine Journal, 45, pp. 170 - 177,
    Journal articles | 2015
    Ghaly S; Martin K; Prosser R; Mill J; Simms LA; Murray K; Radford-Smith GL; Bampton PA; Lawrance IC, 2015, 'Su1268 Serum Vitamin D Binding Protein Concentration Is Associated With Disease Flare in a Cohort of Patients in Crohn's Disease Remission', Gastroenterology, 148, pp. S - 456,
    Journal articles | 2014
    Ghaly S; Costello S; Beswick L; Pudipeddi A; Agarwal A; Sechi A; Headon B; Prosser R; Connor S; Lawrance IC; Sparrow M; Bampton P; Walsh A; Andrews J, 2014, 'Short term dose tailoring of anti TNF-alpha therapy delivers useful clinical efficacy in Crohn's disease patients with secondary loss of response', JOURNAL OF CROHNS & COLITIS, 8, pp. S209 - S209,
    Journal articles | 2014
    Ghaly S; Lawrance I, 2014, 'The role of vitamin D in gastrointestinal inflammation.', Expert Rev Gastroenterol Hepatol, 8, pp. 909 - 923,
    Journal articles | 2008
    Ghaly S; Lourenco R; Abbott J, 2008, 'Audit of endometrial biopsy at outpatient hysteroscopy', Australian and New Zealand Journal of Obstetrics and Gynaecology, 48, pp. 202 - 206,
  • Preprints | 2024
    Tearle JLE; Zhang F; Jackson KJL; Malhotra P; Tavakoli P; Koentgen S; Warren J; Williams C; Haque A; Arzivian A; Tedla N; Kim A; King HW; Hold GL; Ghaly S; James KR, 2024, The primary sclerosing cholangitis and ulcerative colitis colonic mucosa defined through paired microbial and single-cell RNA sequencing,
    Conference Abstracts | 2023
    Pudipeddi A; Paramsothy S; Kariyawasam V; Paramsothy R; Ghaly S; Haifer C; An YK; Begun J; Connor S; Corte C; Ward M; De Cruz P; Fung C; Redmond D; Leong RW, 2023, 'Withdrawal versus continuation of thiopurine in vedolizumab-treated patients with Ulcerative Colitis (VIEWS): a multi-centre randomised controlled trial', in JOURNAL OF CROHNS & COLITIS, OXFORD UNIV PRESS, Vol. 17, pp. 542 - 542,
    Conference Abstracts | 2023
    Suo P; Thin L; Srinivasan A; Winston J; Jeffrey A; Menon S; Ghaly S; Haifer C, 2023, 'Comparing long-term outcomes in inflammatory bowel disease patients between switch and non-switch cohorts: no differences in infliximab persistence or safety outcomes after 54 months', in JOURNAL OF CROHNS & COLITIS, OXFORD UNIV PRESS, Vol. 17, pp. 884 - 884,
    Conference Abstracts | 2022
    Pudipeddi A; Fung C; Kariyawasam V; Paramsothy R; Ghaly S; Haifer C; An Y; Begun J; Connor S; Chetwood J; Paramsothy S; Leong R, 2022, 'HISTOLOGICAL REMISSION USING A NANCY INDEX OF 0 IS ASSOCIATED WITH LONGER RELAPSE-FREE SURVIVAL THAN HISTOLOGICAL ACTIVITY IN PATIENTS WITH ULCERATIVE COLITIS IN CLINICAL AND ENDOSCOPIC REMISSION', in GUT, BMJ PUBLISHING GROUP, Vol. 71, pp. A149 - A150,
    Conference Abstracts | 2021
    Haifer C; Saikal A; Paramsothy S; Borody TJ; Ghaly S; Kaakoush NO; Leong RW, 2021, 'LYOPHILIZED ORALLY ADMINISTERED FECAL MICROBIOTA TRANSPLANTATION IN THE MANAGEMENT OF ULCERATIVE COLITIS (LOTUS STUDY) - RESULTS FROM THE INDUCTION PHASE OF A RANDOMIZED CONTROLLED TRIAL', in GASTROENTEROLOGY, W B SAUNDERS CO-ELSEVIER INC, ELECTR NETWORK, Vol. 160, pp. S135 - S135, presented at Society-for-Surgery-of-the-Alimentary-Tract Annual Meeting at Digestive Disease Week (DDW), ELECTR NETWORK, 21 May 2021 - 23 May 2021,
    Conference Abstracts | 2020
    Choi HH; Venkatesh K; Bliuc D; Center J; Ghaly S, 2020, 'Bone loss is common but under-screened in patients with inflammatory bowel disease', in JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, WILEY, Vol. 35, pp. 128 - 128,
    Conference Posters | 2020
    GU B; Venkatesh K; Williams AJ; Ng W; Corte C; Ghaly S; Xuan W; Paramsothy S; Connor S, 2020, 'P586 Higher infliximab and adalimumab trough levels are associated with fistula healing in patients with fistulising perianal Crohn’s disease', Vol. 14, pp. S490 - S491,
    Conference Abstracts | 2020
    Haifer C; Kelly CR; Paramsothy S; Andresen D; Papanicolas LE; Mckew GL; Borody TJ; Kamm MA; Costello SP; Andrews JM; Begun J; Chan HT; Connor SJ; Ghaly DS; Johnson P; Lemberg D; Paramsothy R; Andrew R; Sheorey H; Van Der Poorten D; Leong RW, 2020, 'Sa1913 CONSENSUS GUIDELINES FOR THE REGULATION, PRODUCTION AND USE OF FECAL MICROBIOTA TRANSPLANTATION IN CLINICAL PRACTICE', in Gastroenterology, Elsevier BV, Vol. 158,
    Conference Papers | 2019
    Greveson K; Inglis C; Ben-Horin S; Ghaly S; Yunki Y; Leong R, 2019, 'Multinational comparisons of practices in overseas travel in Crohn's disease and ulcerative colitis', in JOURNAL OF CROHNS & COLITIS, OXFORD UNIV PRESS, Copenhagen, Denmark, pp. S267 - S267, presented at ECCO, Copenhagen, Denmark, 06 March 2019 - 09 March 2019,
    Conference Abstracts | 2019
    Lim E; Thai M; Hendy P; Alchlaihawi M; Leong R; Connor S; Ng W; Gu B; van Langenberg D; Thin L; Schulberg J; Kamm M; Gilmore R; Taylor K; Sallis O; Andrews J; Daker C; Barclay M; Wark G; Ghaly S; Begun M; Krishnaprasad K; Begun J, 2019, 'Endoscopic balloon dilatation is safe and has a high success rate in patients with stricturing Crohn's disease', in JOURNAL OF CROHNS & COLITIS, OXFORD UNIV PRESS, Vol. 13, pp. S374 - S374,
    Reports | 2016
    Ghaly S, 2016, Iron and vitamin D deficiency in inflammatory bowel disease,
    Conference Papers | 2014
    Costello S; Ghaly S; O'Connor S; Agarwal A; Beswick L; Headon B; Pudipeddi A; Sechi A; Prosser R; Connor S; Sparrow M; Bampton P; Walsh A; Andrews J, 2014, 'Compassionate access use of anti-TNF therapy in ulcerative colitis in six Australian IBD centres has been beneficial to patient outcomes', in JOURNAL OF CROHNS & COLITIS, OXFORD UNIV PRESS, pp. S288 - S288,
    Conference Papers | 2012
    Ghaly S; Gill RS; Keegan MJ; Angus PW; George J; Nicoll AJ; Law M; Sinclair M; Lim LY; Ratnayake H; Dunn A; Strasser SI; Zekry A, 2012, 'Hepatocellular Carcinoma Risk In Chronic Hepatitis B Patients Achieving Viral Suppression With Antiviral Therapy', in HEPATOLOGY, WILEY-BLACKWELL, MA, Boston, pp. 354A - 354A, presented at 63rd Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD), MA, Boston, 09 November 2012 - 13 November 2012,
    Preprints |
    Haifer C; Paramosthy S; Kaakoush NO; Saikal A; Ghaly S; Luu LDW; Borody TJ; Leong RW, Lyophilised Oral Faecal Microbiota Transplantation in Ulcerative Colitis - a Randomised Placebo-Controlled Trial,